SELLAS Life Sciences (SLS) FCF Margin Growth (1y) (2013 - 2022)
Powered by 
Analysis
SELLAS Life Sciences (SLS) FCF Margin Growth (1y) (2013 - 2022) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn | -89.00 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -1,183.00 |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn | 26,102.00 |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | - |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn | 869.00 |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn | 769.00 |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | 811.00 |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | 19,111.00 |
| 10 | SELLAS Life Sciences | 2.66 Bn | 2.66 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2022 | -53,484.00 |
| Jun 30, 2015 | 20,511.00 |
| Mar 31, 2015 | -6,702.00 |
| Dec 31, 2014 | 30,448.00 |
| Sep 30, 2014 | -18,809.00 |
| Jun 30, 2014 | -25,122.00 |
| Mar 31, 2014 | -12,605.00 |
| Dec 31, 2013 | -117,715.00 |
| Sep 30, 2013 | -14,321.00 |